These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry. Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Barrera LA; Kida K; Kubota M; Orii T Mol Genet Metab; 2010 Feb; 99(2):124-31. PubMed ID: 19932038 [TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses. Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440 [TBL] [Abstract][Full Text] [Related]
5. A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses. Langereis EJ; Wagemans T; Kulik W; Lefeber DJ; van Lenthe H; Oussoren E; van der Ploeg AT; Ruijter GJ; Wevers RA; Wijburg FA; van Vlies N PLoS One; 2015; 10(9):e0138622. PubMed ID: 26406883 [TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis. Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903 [TBL] [Abstract][Full Text] [Related]
7. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses. Shimada T; Kelly J; LaMarr WA; van Vlies N; Yasuda E; Mason RW; Mackenzie W; Kubaski F; Giugliani R; Chinen Y; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T; Tomatsu S Mol Genet Metab; 2014; 113(1-2):92-9. PubMed ID: 25092413 [TBL] [Abstract][Full Text] [Related]
8. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses. Zhang H; Wood T; Young SP; Millington DS Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519 [TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III. de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433 [TBL] [Abstract][Full Text] [Related]
10. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry. Kubaski F; Mason RW; Nakatomi A; Shintaku H; Xie L; van Vlies NN; Church H; Giugliani R; Kobayashi H; Yamaguchi S; Suzuki Y; Orii T; Fukao T; Montaño AM; Tomatsu S J Inherit Metab Dis; 2017 Jan; 40(1):151-158. PubMed ID: 27718145 [TBL] [Abstract][Full Text] [Related]
11. Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. Coppa GV; Gabrielli O; Zampini L; Maccari F; Mantovani V; Galeazzi T; Santoro L; Padella L; Marchesiello RL; Galeotti F; Volpi N Metab Brain Dis; 2015 Dec; 30(6):1343-8. PubMed ID: 26016623 [TBL] [Abstract][Full Text] [Related]
12. Newborn screening and diagnosis of mucopolysaccharidoses. Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310 [TBL] [Abstract][Full Text] [Related]
14. UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses. Auray-Blais C; Lavoie P; Tomatsu S; Valayannopoulos V; Mitchell JJ; Raiman J; Beaudoin M; Maranda B; Clarke JT Anal Chim Acta; 2016 Sep; 936():139-48. PubMed ID: 27566349 [TBL] [Abstract][Full Text] [Related]
15. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI. Auray-Blais C; Bhérer P; Gagnon R; Young SP; Zhang HH; An Y; Clarke JT; Millington DS Mol Genet Metab; 2011 Jan; 102(1):49-56. PubMed ID: 20934363 [TBL] [Abstract][Full Text] [Related]
16. Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry. Zhang H; Young SP; Millington DS Curr Protoc Hum Genet; 2013; Chapter 17():Unit 17.12. PubMed ID: 23315926 [TBL] [Abstract][Full Text] [Related]
17. Separation of sulfated urinary glycosaminoglycans by high-resolution electrophoresis for isotyping of mucopolysaccharidoses in Malaysia. Nor A; Zabedah MY; Norsiah MD; Ngu LH; Suhaila AR Malays J Pathol; 2010 Jun; 32(1):35-42. PubMed ID: 20614724 [TBL] [Abstract][Full Text] [Related]
18. Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry. Zhang H; Young SP; Millington DS Curr Protoc; 2023 Mar; 3(3):e701. PubMed ID: 36929617 [TBL] [Abstract][Full Text] [Related]
19. A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses. Chuang CK; Lin HY; Wang TJ; Tsai CC; Liu HL; Lin SP Orphanet J Rare Dis; 2014 Sep; 9():135. PubMed ID: 25178307 [TBL] [Abstract][Full Text] [Related]
20. Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases. Langford-Smith KJ; Mercer J; Petty J; Tylee K; Church H; Roberts J; Moss G; Jones S; Wynn R; Wraith JE; Bigger BW J Inherit Metab Dis; 2011 Apr; 34(2):499-508. PubMed ID: 21170681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]